Innovus Pharmaceuticals Inc (OTCMKTS:INNVD – Get Free Report) shares traded up 143.9% on Monday . The stock traded as high as $3.49 and last traded at $3.00. 4,300 shares changed hands during mid-day trading, a decline of 55% from the average session volume of 9,592 shares. The stock had previously closed at $1.23.
Innovus Pharmaceuticals Trading Up 143.9 %
The firm has a market capitalization of $7.07 million, a P/E ratio of -0.72 and a beta of 2.89. The firm’s 50-day moving average is $3.00.
About Innovus Pharmaceuticals
Innovus Pharmaceuticals, Inc, a pharmaceutical company, engages in the development, licensing, and commercialization of non-prescription medicines and consumer care products in the United States. Its products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream for penile sensitivity; Zestra Glide, a water-based longer lasting lubricant; Vesele, a proprietary oral supplement for promoting sexual health; and Androferti, a natural supplement to support male reproductive health and sperm quality.
See Also
- Five stocks we like better than Innovus Pharmaceuticals
- With Risk Tolerance, One Size Does Not Fit All
- Inflation Risk Rising, Key Trades Investors Are Making Now
- ETF Screener: Uses and Step-by-Step Guide
- 3 Oil Stocks to Watch Before Earnings Come Out
- Overbought Stocks Explained: Should You Trade Them?
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for Innovus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
